IDiyas

For the Inventor, By the Inventor

Vaerlose, Denmark

Ole Buchardt

USPTO Granted Patents = 21


Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 1,200(Granted Patents)


Location History:

  • DK-3500 Vaerloese, DK (1991)
  • DK 3500 Vaerlose, DK (1996 - 2001)
  • late of Værløse, DE (2002)
  • late of Værløse, DK (2003)
  • late of Vaerlose, DK (2001 - 2004)
  • late of Værlose, DK (2004)
  • Vaerlose, DK (1987 - 2007)
  • 3500 Værløse, DK (2002 - 2008)

Company Filing History:

goldMedal4 out of 1,035 
 
Isis Pharmaceuticals, Inc.
 patents
silverMedal1 out of 1 
 
Pharma-medica A-s
 patent
bronzeMedal19 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1987-2008

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents
1. 7378485 - Peptide nucleic acids with polyamide-containing backbones (2008-05-27),
2. 7223833 - Peptide nucleic acid conjugates (2007-05-29),
3. 6770738 - Higher order structure and binding of peptide nucleic acids (2004-08-03),
4. 6713602 - Synthetic procedures for peptide nucleic acids (2004-03-30),
5. 6710164 - Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility (2004-03-23),
6. 6710163 - Peptide nucleic acid synthons (2004-03-23),
7. 6613873 - Peptide nucleic acids having 2,6-diaminopurine nucleobases (2003-09-02),
8. 6610650 - Modulation of cellular transcription factor activity (2003-08-26),
9. 6451968 - Peptide nucleic acids (2002-09-17),
10. 6441130 - Linked peptide nucleic acids (2002-08-27),
11. 6414112 - Peptide nucleic acids having 2,6-diaminopurine nucleobases (2002-07-02),
12. 6395474 - Peptide nucleic acids (2002-05-28),
13. 6357163 - Use of nucleic acid analogues in diagnostics and analytical procedures (2002-03-19),
14. 6228982 - Double-stranded peptide nucleic acids (2001-05-08),
15. 6201103 - Peptide nucleic acid incorporating a chiral backbone (2001-03-13),

Title: Ole Buchardt: Innovating in Peptide Nucleic Acids

Introduction

Ole Buchardt is an accomplished inventor based in Vaerlose, Denmark, with a remarkable portfolio of 21 patents to his name. His work primarily focuses on the development of innovative compounds that enhance our understanding and capabilities in molecular biology.

Latest Patents

Buchardt's latest contributions to the field include patents for peptide nucleic acids with polyamide-containing backbones. These novel compounds are designed to bind complementary single-stranded DNA (ssDNA) and RNA strands with greater affinity than traditional DNA examples. The design of these peptide nucleic acids incorporates naturally occurring DNA bases that are attached to a peptide backbone via a suitable linker, greatly enhancing their functionality. Additionally, he has developed peptide nucleic acid conjugates, which represent another class of these groundbreaking compounds, further solidifying his impact on genetic engineering and molecular diagnostics.

Career Highlights

Throughout his career, Ole Buchardt has made significant strides in the field of biotechnology. His contributions have positioned him as a thought leader in the domain of peptide nucleic acids, an area that holds substantial promise for applications ranging from gene therapy to diagnostics.

Collaborations

His innovative work has often been in collaboration with notable colleagues, including Peter Eigil Nielsen and Michael Egholm. These partnerships have propelled advances in research and development, underscoring the collaborative nature of scientific innovation.

Conclusion

Ole Buchardt's commitment to pushing the boundaries of biotechnology through his patents exemplifies the spirit of innovation that drives the industry forward. With a notable portfolio and impactful collaborations, he continues to contribute valuable insights and developments that may redefine molecular interactions in biomedicine and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…